-
2
-
-
0035892032
-
Treatment of acute hepatitis C with interferon alfa-2b
-
Jaeckel E, Cornberg M, Wedemeyer H, Santantonio T, Mayer J, et al. (2001) Treatment of acute hepatitis C with interferon alfa-2b. N Engl J Med 345: 1452-1457.
-
(2001)
N Engl J Med
, vol.345
, pp. 1452-1457
-
-
Jaeckel, E.1
Cornberg, M.2
Wedemeyer, H.3
Santantonio, T.4
Mayer, J.5
-
3
-
-
54549108005
-
Treatment of acute hepatitis C: The success of monotherapy with (pegylated) interferon alpha
-
Wiegand J, Deterding K, Cornberg M, Wedemeyer H (2008) Treatment of acute hepatitis C: the success of monotherapy with (pegylated) interferon alpha. J Antimicrob Chemother 62: 860-865.
-
(2008)
J Antimicrob Chemother
, vol.62
, pp. 860-865
-
-
Wiegand, J.1
Deterding, K.2
Cornberg, M.3
Wedemeyer, H.4
-
4
-
-
19044361835
-
Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection
-
DOI 10.1053/j.gastro.2005.01.059, PII S0016508505003999
-
Chen L, Borozan I, Feld J, Sun J, Tannis LL, et al. (2005) Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection. Gastroenterology 128: 1437-1444. (Pubitemid 40712193)
-
(2005)
Gastroenterology
, vol.128
, Issue.5
, pp. 1437-1444
-
-
Chen, L.1
Borozan, I.2
Feld, J.3
Sun, J.4
Tannis, L.-L.5
Coltescu, C.6
Heathcote, J.7
Edwards, A.M.8
McGilvray, I.D.9
-
5
-
-
44349109098
-
Interferon signaling and treatment outcome in chronic hepatitis C
-
DOI 10.1073/pnas.0707882105
-
Sarasin-Filipowicz M, Oakeley EJ, Duong FH, Christen V, Terracciano L, et al. (2008) Interferon signaling and treatment outcome in chronic hepatitis C. Proc Natl Acad Sci U S A 105: 7034-7039. (Pubitemid 351754525)
-
(2008)
Proceedings of the National Academy of Sciences of the United States of America
, vol.105
, Issue.19
, pp. 7034-7039
-
-
Sarasin-Filipowicz, M.1
Oakeley, E.J.2
Duong, F.H.T.3
Christen, V.4
Terracciano, L.5
Filipowicz, W.6
Heim, M.H.7
-
6
-
-
36348960622
-
Hepatic gene expression during treatment with peginterferon and ribavirin: Identifying molecular pathways for treatment response
-
Feld JJ, Nanda S, Huang Y, Chen W, Cam M, et al. (2007) Hepatic gene expression during treatment with peginterferon and ribavirin: Identifying molecular pathways for treatment response. Hepatology.
-
(2007)
Hepatology
-
-
Feld, J.J.1
Nanda, S.2
Huang, Y.3
Chen, W.4
Cam, M.5
-
7
-
-
70349292099
-
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
-
Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, et al. (2009) Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461: 399-401.
-
(2009)
Nature
, vol.461
, pp. 399-401
-
-
Ge, D.1
Fellay, J.2
Thompson, A.J.3
Simon, J.S.4
Shianna, K.V.5
-
8
-
-
70349533037
-
Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C
-
Tanaka Y, Nishida N, Sugiyama M, Kurosaki M, Matsuura K, et al. (2009) Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet 41: 1105-1109.
-
(2009)
Nat Genet
, vol.41
, pp. 1105-1109
-
-
Tanaka, Y.1
Nishida, N.2
Sugiyama, M.3
Kurosaki, M.4
Matsuura, K.5
-
9
-
-
70349548852
-
IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy
-
Suppiah V, Moldovan M, Ahlenstiel G, Berg T, Weltman M, et al. (2009) IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nat Genet 41: 1100-1104.
-
(2009)
Nat Genet
, vol.41
, pp. 1100-1104
-
-
Suppiah, V.1
Moldovan, M.2
Ahlenstiel, G.3
Berg, T.4
Weltman, M.5
-
10
-
-
84862777615
-
Hepatic cell-type specific gene expression better predicts HCV treatment outcome than IL28B genotype
-
McGilvray I, Feld JJ, Chen L, Pattullo V, Guindi M, et al. (2012) Hepatic cell-type specific gene expression better predicts HCV treatment outcome than IL28B genotype. Gastroenterology 142: 1122-1131 e1121.
-
(2012)
Gastroenterology
, vol.142
-
-
McGilvray, I.1
Feld, J.J.2
Chen, L.3
Pattullo, V.4
Guindi, M.5
-
11
-
-
77955475888
-
Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C
-
Honda M, Sakai A, Yamashita T, Nakamoto Y, Mizukoshi E, et al. (2010) Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C. Gastroenterology 139: 499-509.
-
(2010)
Gastroenterology
, vol.139
, pp. 499-509
-
-
Honda, M.1
Sakai, A.2
Yamashita, T.3
Nakamoto, Y.4
Mizukoshi, E.5
-
12
-
-
84873083416
-
A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus
-
Prokunina-Olsson L, Muchmore B, Tang W, Pfeiffer RM, Park H, et al. (2013) A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus. Nat Genet 45: 164-171.
-
(2013)
Nat Genet
, vol.45
, pp. 164-171
-
-
Prokunina-Olsson, L.1
Muchmore, B.2
Tang, W.3
Pfeiffer, R.M.4
Park, H.5
-
13
-
-
33144462713
-
Association of pretreatment serum interferon gamma inducible protein 10 levels with sustained virological response to peginterferon plus ribavirin therapy in genotype 1 infected patients with chronic hepatitis C
-
DOI 10.1136/gut.2005.074062
-
Diago M, Castellano G, Garcia-Samaniego J, Perez C, Fernandez I, et al. (2006) Association of pretreatment serum interferon gamma inducible protein 10 levels with sustained virological response to peginterferon plus ribavirin therapy in genotype 1 infected patients with chronic hepatitis C. Gut 55: 374-379. (Pubitemid 43268277)
-
(2006)
Gut
, vol.55
, Issue.3
, pp. 374-379
-
-
Diago, M.1
Castellano, G.2
Garcia-Samaniego, J.3
Perez, C.4
Fernandez, I.5
Romero, M.6
Iacono, O.L.7
Garcia-Monzon, C.8
-
14
-
-
33845662689
-
IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection
-
DOI 10.1002/hep.21407
-
Lagging M, Romero AI, Westin J, Norkrans G, Dhillon AP, et al. (2006) IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection. Hepatology 44: 1617-1625. (Pubitemid 44953667)
-
(2006)
Hepatology
, vol.44
, Issue.6
, pp. 1617-1625
-
-
Lagging, M.1
Romero, A.I.2
Westin, J.3
Norkrans, G.4
Dhillon, A.P.5
Pawlotsky, J.-M.6
Zeuzem, S.7
Von Wagner, M.8
Negro, F.9
Schalm, S.W.10
Haagmans, B.L.11
Ferrari, C.12
Missale, G.13
Neumann, A.U.14
Verheij-Hart, E.15
Hellstrand, K.16
-
15
-
-
33749017951
-
Interferon (IFN)-gamma-inducible protein-10: Association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha2a and ribavirin for chronic hepatitis C virus infection
-
DOI 10.1086/507307
-
Romero AI, Lagging M, Westin J, Dhillon AP, Dustin LB, et al. (2006) Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection. J Infect Dis 194: 895-903. (Pubitemid 44454074)
-
(2006)
Journal of Infectious Diseases
, vol.194
, Issue.7
, pp. 895-903
-
-
Romero, A.I.1
Lagging, M.2
Westin, J.3
Dhillon, A.P.4
Dustin, L.B.5
Pawlotsky, J.-M.6
Neumann, A.U.7
Ferrari, C.8
Missale, G.9
Haagmans, B.L.10
Schalm, S.W.11
Zeuzem, S.12
Negro, F.13
Verheij-Hart, E.14
Hellstrand, K.15
-
16
-
-
34347336666
-
The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection
-
DOI 10.1111/j.1365-2893.2006.00838.x
-
Zeremski M, Petrovic LM, Talal AH (2007) The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection. J Viral Hepat 14: 675-687. (Pubitemid 47414927)
-
(2007)
Journal of Viral Hepatitis
, vol.14
, Issue.10
, pp. 675-687
-
-
Zeremski, M.1
Petrovic, L.M.2
Talal, A.H.3
-
17
-
-
77951576906
-
Systemic and intrahepatic interferon-gamma-inducible protein 10 kDa predicts the first-phase decline in hepatitis C virus RNA and overall viral response to therapy in chronic hepatitis C
-
Askarieh G, Alsio A, Pugnale P, Negro F, Ferrari C, et al. (2010) Systemic and intrahepatic interferon-gamma-inducible protein 10 kDa predicts the first-phase decline in hepatitis C virus RNA and overall viral response to therapy in chronic hepatitis C. Hepatology 51: 1523-1530.
-
(2010)
Hepatology
, vol.51
, pp. 1523-1530
-
-
Askarieh, G.1
Alsio, A.2
Pugnale, P.3
Negro, F.4
Ferrari, C.5
-
18
-
-
72249093341
-
Effective treatment of injecting drug users with recently acquired hepatitis C virus infection
-
Dore GJ, Hellard M, Matthews GV, Grebely J, Haber PS, et al. (2010) Effective treatment of injecting drug users with recently acquired hepatitis C virus infection. Gastroenterology 138: 123-135 e121-122.
-
(2010)
Gastroenterology
, vol.138
-
-
Dore, G.J.1
Hellard, M.2
Matthews, G.V.3
Grebely, J.4
Haber, P.S.5
-
19
-
-
84859164566
-
Hepatitis C virus reinfection and superinfection among treated and untreated participants with recent infection
-
Grebely J, Pham ST, Matthews GV, Petoumenos K, Bull RA, et al. (2012) Hepatitis C virus reinfection and superinfection among treated and untreated participants with recent infection. Hepatology 55: 1058-1069.
-
(2012)
Hepatology
, vol.55
, pp. 1058-1069
-
-
Grebely, J.1
Pham, S.T.2
Matthews, G.V.3
Petoumenos, K.4
Bull, R.A.5
-
20
-
-
84879080767
-
Plasma interferon-gamma-inducible protein-10 (IP-10) levels during acute hepatitis C virus infection
-
In Press
-
Grebely J, Feld JJ, Applegate T, Matthews GV, Hellard M, et al. (2013) Plasma interferon-gamma-inducible protein-10 (IP-10) levels during acute hepatitis C virus infection. Hepatology In Press.
-
(2013)
Hepatology
-
-
Grebely, J.1
Feld, J.J.2
Applegate, T.3
Matthews, G.V.4
Hellard, M.5
-
21
-
-
84879080767
-
Plasma interferon-gamma-inducible protein-10 (IP-10) levels during acute hepatitis C virus infection
-
Grebely J, Feld JJ, Applegate T, Matthews GV, Hellard M, et al. (2013) Plasma interferon-gamma-inducible protein-10 (IP-10) levels during acute hepatitis C virus infection. Hepatology 57: 2124-2134.
-
(2013)
Hepatology
, vol.57
, pp. 2124-2134
-
-
Grebely, J.1
Feld, J.J.2
Applegate, T.3
Matthews, G.V.4
Hellard, M.5
-
22
-
-
77957965687
-
Potential role for interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection
-
Grebely J, Petoumenos K, Hellard M, Matthews GV, Suppiah V, et al. (2010) Potential role for interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection. Hepatology 52: 1216-1224.
-
(2010)
Hepatology
, vol.52
, pp. 1216-1224
-
-
Grebely, J.1
Petoumenos, K.2
Hellard, M.3
Matthews, G.V.4
Suppiah, V.5
-
23
-
-
79952097683
-
Response Prediction in Chronic Hepatitis C by Assessment of IP-10 and IL28B-Related Single Nucleotide Polymorphisms
-
Lagging M, Askarieh G, Negro F, Bibert S, Soderholm J, et al. (2011) Response Prediction in Chronic Hepatitis C by Assessment of IP-10 and IL28B-Related Single Nucleotide Polymorphisms. Plos One 6: e17232.
-
(2011)
Plos One
, vol.6
-
-
Lagging, M.1
Askarieh, G.2
Negro, F.3
Bibert, S.4
Soderholm, J.5
-
24
-
-
78549268213
-
IP-10 predicts the first phase decline of HCV RNA and overall viral response to therapy in patients co-infected with chronic hepatitis C virus infection and HIV
-
Falconer K, Askarieh G, Weis N, Hellstrand K, Alaeus A, et al. (2010) IP-10 predicts the first phase decline of HCV RNA and overall viral response to therapy in patients co-infected with chronic hepatitis C virus infection and HIV. Scand J Infect Dis 42: 896-901.
-
(2010)
Scand J Infect Dis
, vol.42
, pp. 896-901
-
-
Falconer, K.1
Askarieh, G.2
Weis, N.3
Hellstrand, K.4
Alaeus, A.5
-
25
-
-
84864040447
-
Detection of host immune responses in acute phase sera of spontaneous resolution versus persistent hepatitis C virus infection
-
Selvarajah S, Keating S, Heitman J, Lu K, Simmons G, et al. (2012) Detection of host immune responses in acute phase sera of spontaneous resolution versus persistent hepatitis C virus infection. J Gen Virol 93: 1673-1679.
-
(2012)
J Gen Virol
, vol.93
, pp. 1673-1679
-
-
Selvarajah, S.1
Keating, S.2
Heitman, J.3
Lu, K.4
Simmons, G.5
-
26
-
-
78751492246
-
Quantitation of pretreatment serum interferon-gamma-inducible protein-10 improves the predictive value of an IL28B gene polymorphism for hepatitis C treatment response
-
Darling JM, Aerssens J, Fanning G, McHutchison JG, Goldstein DB, et al. (2011) Quantitation of pretreatment serum interferon-gamma-inducible protein-10 improves the predictive value of an IL28B gene polymorphism for hepatitis C treatment response. Hepatology 53: 14-22.
-
(2011)
Hepatology
, vol.53
, pp. 14-22
-
-
Darling, J.M.1
Aerssens, J.2
Fanning, G.3
McHutchison, J.G.4
Goldstein, D.B.5
-
27
-
-
78650962504
-
Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV
-
Casrouge A, Decalf J, Ahloulay M, Lababidi C, Mansour H, et al. (2011) Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV. J Clin Invest 121: 308-317.
-
(2011)
J Clin Invest
, vol.121
, pp. 308-317
-
-
Casrouge, A.1
Decalf, J.2
Ahloulay, M.3
Lababidi, C.4
Mansour, H.5
-
28
-
-
78049469161
-
A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice
-
Tillmann HL, Thompson AJ, Patel K, Wiese M, Tenckhoff H, et al. (2010) A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice. Gastroenterology 139: 1586-1592, 1592 e1581.
-
(2010)
Gastroenterology
, vol.139
-
-
Tillmann, H.L.1
Thompson, A.J.2
Patel, K.3
Wiese, M.4
Tenckhoff, H.5
-
29
-
-
84865460821
-
Interferon-gamma-stimulated genes, but not USP18, are expressed in livers of patients with acute hepatitis C
-
Dill MT, Makowska Z, Duong FH, Merkofer F, Filipowicz M, et al. (2012) Interferon-gamma-stimulated genes, but not USP18, are expressed in livers of patients with acute hepatitis C. Gastroenterology 143: 777-786 e771-776.
-
(2012)
Gastroenterology
, vol.143
-
-
Dill, M.T.1
Makowska, Z.2
Duong, F.H.3
Merkofer, F.4
Filipowicz, M.5
-
30
-
-
68849111675
-
Hepatitis C virus versus innate and adaptive immune responses: A tale of coevolution and coexistence
-
Rehermann B (2009) Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence. J Clin Invest 119: 1745-1754.
-
(2009)
J Clin Invest
, vol.119
, pp. 1745-1754
-
-
Rehermann, B.1
-
31
-
-
84870454347
-
Treatment indication and response to standard of care with peginterferon and ribavirin in acute and chronic HCV infection
-
Feld JJ (2012) Treatment indication and response to standard of care with peginterferon and ribavirin in acute and chronic HCV infection. Best Pract Res Clin Gastroenterol 26: 429-444.
-
(2012)
Best Pract Res Clin Gastroenterol
, vol.26
, pp. 429-444
-
-
Feld, J.J.1
-
32
-
-
33644875265
-
Spontaneous viral clearance following acute hepatitis C infection: A systematic review of longitudinal studies
-
Micallef JM, Kaldor JM, Dore GJ (2006) Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies. J Viral Hepat 13: 34-41.
-
(2006)
J Viral Hepat
, vol.13
, pp. 34-41
-
-
Micallef, J.M.1
Kaldor, J.M.2
Dore, G.J.3
-
33
-
-
68849096074
-
Alpha interferon induces long-lasting refractoriness of JAK-STAT signaling in the mouse liver through induction of USP18/UBP43
-
Sarasin-Filipowicz M, Wang X, Yan M, Duong FH, Poli V, et al. (2009) Alpha interferon induces long-lasting refractoriness of JAK-STAT signaling in the mouse liver through induction of USP18/UBP43. Mol Cell Biol 29: 4841-4851.
-
(2009)
Mol Cell Biol
, vol.29
, pp. 4841-4851
-
-
Sarasin-Filipowicz, M.1
Wang, X.2
Yan, M.3
Duong, F.H.4
Poli, V.5
-
34
-
-
79953732320
-
Interferon-beta and interferon-lambda signaling is not affected by interferon-induced refractoriness to interferon-alpha in vivo
-
Makowska Z, Duong FH, Trincucci G, Tough DF, Heim MH (2011) Interferon-beta and interferon-lambda signaling is not affected by interferon-induced refractoriness to interferon-alpha in vivo. Hepatology 53: 1154-1163.
-
(2011)
Hepatology
, vol.53
, pp. 1154-1163
-
-
Makowska, Z.1
Duong, F.H.2
Trincucci, G.3
Tough, D.F.4
Heim, M.H.5
-
35
-
-
79960313095
-
USP18-based negative feedback control is induced by type I and type III interferons and specifically inactivates interferon alpha response
-
Francois-Newton V, Magno de Freitas Almeida G, Payelle-Brogard B, Monneron D, Pichard-Garcia L, et al. (2011) USP18-based negative feedback control is induced by type I and type III interferons and specifically inactivates interferon alpha response. PLoS One 6: e22200.
-
(2011)
PLoS One
, vol.6
-
-
Francois-Newton, V.1
Magno De Freitas Almeida, G.2
Payelle-Brogard, B.3
Monneron, D.4
Pichard-Garcia, L.5
-
36
-
-
79954756911
-
Interferon-lambda serum levels in hepatitis C
-
Langhans B, Kupfer B, Braunschweiger I, Arndt S, Schulte W, et al. (2011) Interferon-lambda serum levels in hepatitis C. J Hepatol 54: 859-865.
-
(2011)
J Hepatol
, vol.54
, pp. 859-865
-
-
Langhans, B.1
Kupfer, B.2
Braunschweiger, I.3
Arndt, S.4
Schulte, W.5
-
37
-
-
82455188188
-
Hepatitis C virus induces interferon-lambda and interferon-stimulated genes in primary liver cultures
-
Marukian S, Andrus L, Sheahan TP, Jones CT, Charles ED, et al. (2011) Hepatitis C virus induces interferon-lambda and interferon-stimulated genes in primary liver cultures. Hepatology 54: 1913-1923.
-
(2011)
Hepatology
, vol.54
, pp. 1913-1923
-
-
Marukian, S.1
Andrus, L.2
Sheahan, T.P.3
Jones, C.T.4
Charles, E.D.5
-
38
-
-
1542377471
-
Antiviral Action of Ribavirin in Chronic Hepatitis C
-
DOI 10.1053/j.gastro.2003.12.002
-
Pawlotsky JM, Dahari H, Neumann AU, Hezode C, Germanidis G, et al. (2004) Antiviral action of ribavirin in chronic hepatitis C. Gastroenterology 126: 703-714. (Pubitemid 38298318)
-
(2004)
Gastroenterology
, vol.126
, Issue.3
, pp. 703-714
-
-
Pawlotsky, J.-M.1
Dahari, H.2
Neumann, A.U.3
Hezode, C.4
Germanidis, G.5
Lonjon, I.6
Castera, L.7
Dhumeaux, D.8
-
39
-
-
36348960622
-
Hepatic gene expression during treatment with peginterferon and ribavirin: Identifying molecular pathways for treatment response
-
DOI 10.1002/hep.21853
-
Feld JJ, Nanda S, Huang Y, Chen W, Cam M, et al. (2007) Hepatic gene expression during treatment with peginterferon and ribavirin: Identifying molecular pathways for treatment response. Hepatology 46: 1548-1563. (Pubitemid 350155537)
-
(2007)
Hepatology
, vol.46
, Issue.5
, pp. 1548-1563
-
-
Feld, J.J.1
Nanda, S.2
Huang, Y.3
Chen, W.4
Cam, M.5
Pusek, S.N.6
Schweigler, L.M.7
Theodore, D.8
Zacks, S.L.9
Liang, T.J.10
Fried, M.W.11
-
40
-
-
78751545582
-
Ribavirin potentiates interferon action by augmenting interferon-stimulated gene induction in hepatitis C virus cell culture models
-
Thomas E, Feld JJ, Li Q, Hu Z, Fried MW, et al. (2011) Ribavirin potentiates interferon action by augmenting interferon-stimulated gene induction in hepatitis C virus cell culture models. Hepatology 53: 32-41.
-
(2011)
Hepatology
, vol.53
, pp. 32-41
-
-
Thomas, E.1
Feld, J.J.2
Li, Q.3
Hu, Z.4
Fried, M.W.5
-
41
-
-
77953893773
-
Ribavirin improves early responses to peginterferon through improved interferon signaling
-
Feld JJ, Lutchman GA, Heller T, Hara K, Pfeiffer JK, et al. (2010) Ribavirin improves early responses to peginterferon through improved interferon signaling. Gastroenterology 139: 154-162 e154.
-
(2010)
Gastroenterology
, vol.139
-
-
Feld, J.J.1
Lutchman, G.A.2
Heller, T.3
Hara, K.4
Pfeiffer, J.K.5
-
42
-
-
11144330097
-
Modelling how ribavirin improves interferon response rates in hepatitis C virus infection
-
DOI 10.1038/nature03153
-
Dixit NM, Layden-Almer JE, Layden TJ, Perelson AS (2004) Modelling how ribavirin improves interferon response rates in hepatitis C virus infection. Nature 432: 922-924. (Pubitemid 40037156)
-
(2004)
Nature
, vol.432
, Issue.7019
, pp. 922-924
-
-
Dixit, H.M.1
Layden-Almer, J.E.2
Layden, T.J.3
Perelson, A.S.4
|